ATTEST-Depress: ATtention Test and Executive Functions After STroke to Predict Depression.

Sponsor
Centre Hospitalier St Anne (Other)
Overall Status
Completed
CT.gov ID
NCT04008719
Collaborator
(none)
74
1
1
28.5
2.6

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether cognitive function evaluation (sustained attention, executive functions, working memory) during acute post-stroke is predictive of a 3 months post-stroke depression.

Condition or Disease Intervention/Treatment Phase
  • Other: Thymic history
  • Other: Evaluation of the psychiatric disorders
  • Other: Cognitive evaluation
N/A

Detailed Description

  1. Baseline visit: after neurologic stability, 14 days or less after stroke and before discharge.

  2. First assessment :

  3. Neurologic data: morphologic data (MRI of the brain), stroke severity (NIHSScore), aphasia assessment (Boston Diagnostic Aphasia Examination) if NIHS verbal score ≥1, hemineglect assessment (Bells test).

  4. Personal data assessment :

  1. Socio demographic : age, gender, marital status, employment, level of education ii. Medical history: medical treatments, psychiatric and non psychiatric history.

  2. Psychiatric assessment i. Mini International Neuropsychiatric Interview - depression

  1. Beck Depression Inventory iii. Clinical Global Impression iv. Standardized Assessment of Personality - Abbreviated Scale (SAPAS) v. Fageström-C vi. Alcohol Use
Disorders Identification Test (AUDIT-C) d. Cognitive assessment: i. Verbal memory :

Dubois's five words ii. Clock drawing test iii. D2test (computerized) iv. Verbal fluency (Cardebat) v. Working memory (digit span WAIS 3) vi. Brixton (computerized)

  1. Assessment 3 months after the first assessment. Phone call and psychiatric assessment: MINI depression, Beck Depression Inventory. Barthel index and Quality of Life assessment.

Study Design

Study Type:
Interventional
Actual Enrollment :
74 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Predictivity of Attention Test and Executive Functions After Stroke to Predict Depression 3 Months After Stroke.
Actual Study Start Date :
May 16, 2017
Actual Primary Completion Date :
Sep 30, 2019
Actual Study Completion Date :
Sep 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: Patients

Assessments are made by a psychiatrist

Other: Thymic history
This interview concerns mainly the nature of the previous psychiatric and psychological care

Other: Evaluation of the psychiatric disorders
Mini International Neuropsychiatric Interview for the positive diagnosis of depression - under the MINI score of depression.

Other: Cognitive evaluation
They will be held consecutively to the patient's bedside interview on the same day. Some tests will be computerized, others will be in paper form.

Outcome Measures

Primary Outcome Measures

  1. Post stroke depression [3 months]

    Whether or not a post-stroke depression occurs. occurrence of post-stroke depression assessed with Mini International Neuropsychiatric Interview (MINI), subscale depression .

Secondary Outcome Measures

  1. Post-stroke depression population characterization [1 day]

    Age, gender, marital status, occupation, level of education, laterality of stroke,and medical and psychiatric history will be collected during the inclusion interview and cognitive tests

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 or more

  • Ischemic or hemorragic stroke, diagnosed with radiology : cerebral CT or MRI, 14 days or less after stroke

  • Signed Consent

  • Social insurance regime affiliation

Exclusion Criteria:
  • Death

  • No possibility of follow-up

  • No French-speaker : insufficient command of French

  • Deprivation of liberty : judicial or administrative decision

  • D2 test assessment impossibility

  • Aphasia with major disorder of the understanding (Boston <8)

  • Antidepressant treatment during stroke

  • Depression during stroke

  • protected people

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neurology service Paris France 75014

Sponsors and Collaborators

  • Centre Hospitalier St Anne

Investigators

  • Study Director: Philip GORWOOD, MD, PhD, CHSA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier St Anne
ClinicalTrials.gov Identifier:
NCT04008719
Other Study ID Numbers:
  • D17-P02
First Posted:
Jul 5, 2019
Last Update Posted:
May 28, 2021
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier St Anne
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 28, 2021